The degree to which electronic cigarettes stimulate or depress overall interest in quitting is a separate and empirically answerable question. In fact, evidence from the UK indicates that the spread of electronic cigarettes has been associated with a in the desire to quit smoking at a population level.

Included in a recent editorial, Dr. Michael Katz mentioned that the FDA should monitor electronic cigarettes as a nicotine delivery tool, and that electronic cigarettes should continue to be banned in locations where typical tobacco products are not allowed. “Unfortunately, the evidence on whether e-cigarettes help smokers to quit is contradictory and inconclusive,” Katz wrote. He did say he was willing to support their use if “there were good data indicating that they helped smokers to stop.” Dr. Gilbert Ross, medical and executive director of The American Council on Science and Health, said “allowing e-cigs to compete with cigarettes in the marketplace might decrease smoking-related morbidity and mortality.”

Financial interests in Big Pharma must now be recognized as conflicts of interest for any organization or individual who is offering opinions about national strategy, policy, or regulations regarding electronic cigarettes. Therefore, the authors of all scientific articles regarding electronic cigarettes must disclose any financial interests with pharmaceutical companies. Furthermore, organizations must also disclose any financial ties to Big Pharma when they offer recommendations regarding electronic cigarette policy.

LAST：CECO ecigarette CE5, ce5 wickless clearomizer, replacement parts clearomizer ce5 |NEXT：hot selling best price 18650 Battery e-cig revolver mech mod